J&J to close down Leiden based vaccination unit Janssen

Belgian pharmaceuticals company Janssen, which is part of the Johnson & Johnson group, is planning to close most of its infectious diseases and vaccine development unit in Leiden. Janssen has a workforce of 2,500 in Leiden and it is unclear, as yet, how many jobs will be affected by the closure which still needs to be approved by the works council. J&J wants the unit to focus more on new treatment methods for cancer and heart and artery disease, the...